AgenTus Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- AgenTus Therapeutics's estimated annual revenue is currently $11.5M per year.
- AgenTus Therapeutics's estimated revenue per employee is $155,000
Employee Data
- AgenTus Therapeutics has 74 Employees.
- AgenTus Therapeutics grew their employee count by 10% last year.
AgenTus Therapeutics's People
| Name | Title | Email/Phone |
|---|
AgenTus Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is AgenTus Therapeutics?
AgenTus Therapeutics, a biopharmaceutical company, is focused on the discovery, development, and commercialization of breakthrough living drugs to advance cures for cancer patients. AgenTus will employ naturally-derived and engineered receptors, specifically T Cell Receptors (TCRs) and Chimeric Antigen Receptors (CARs), designed to supercharge human immune effector cells to seek and destroy cancer. AgenTus will also aim to advance adoptive cell therapy formats which would enable off-the-shelf living drugs.
keywords:N/A
N/A
Total Funding
74
Number of Employees
$11.5M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Lexington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $21.5M | 74 | 9% | N/A |
#2 | $9.7M | 74 | 3% | N/A |
#3 | $12.2M | 75 | 79% | N/A |
#4 | $7.5M | 75 | 3% | N/A |
#5 | $21.9M | 75 | 0% | N/A |